← Open Payments lookup

SARAH SULLIVAN: Open Payments

NPI 1407856727 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$559 in 22 payments from 12 companies in 2025. Trend: 2023 $364 · 2024 $456 · 2025 $559

Food & beverage: $559
CompanyPaymentsAmount
Dexcom, Inc.2$165
ABBVIE INC.3$74
PFIZER INC.4$69
Bayer Healthcare Pharmaceuticals Inc.2$47
Astellas Pharma US Inc2$40
Sumitomo Pharma America, Inc.2$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
AstraZeneca Pharmaceuticals LP1$18
Amgen Inc.1$16

Products named: Dexcom G6 Transmitter, VRAYLAR, ELIQUIS, Kerendia, Veozah, GEMTESA, XIFAXAN, CAPLYTA.

Industry payments across MD — which companies pay providers there.